Litcius/Paper detail

Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions

Fan Zhang, Xudong Cao, Chunhui Zhao, Li Chen, Xiaolin Chen

2022Journal of Thrombosis and Thrombolysis15 citationsDOI

Topics & Concepts

MedicineEmpagliflozinEMPADiabetes mellitusOxidative stressHypoxia (environmental)ApoptosisSTAT3Internal medicinePharmacologyReperfusion injuryEndocrinologyIschemiaType 2 Diabetes MellitusBiologyChemistryBiochemistryOrganic chemistryMineralogyElectron microprobeOxygenDiabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer
Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions | Litcius